Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr;10(4):828-836.
doi: 10.1111/j.1600-6143.2010.03047.x.

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study

R Grenda  1 , A Watson  2 , R Trompeter  3 , B Tönshoff  4 , J Jaray  5 , M Fitzpatrick  6 , L Murer  7 , K Vondrak  8 , H Maxwell  9 , R Van Damme-Lombaerts  10 , C Loirat  11 , E Mor  12 , P Cochat  13 , D V Milford  14 , M Brown  15 , N J A Webb  16
Affiliations
Free article
Randomized Controlled Trial

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study

R Grenda et al. Am J Transplant. 2010 Apr.
Free article

Abstract

Minimizing steroid exposure in pediatric renal transplant recipients can improve linear growth and reduce metabolic disorders. This randomized multicenter study investigated the impact of early steroid withdrawal on mean change in height standard deviation score (SDS) and the safety and efficacy of two immunosuppressive regimens during the first 6 months after transplantation. Children received tacrolimus, MMF, two doses of daclizumab and steroids until day 4 (TAC/MMF/DAC, n=98) or tacrolimus, MMF and standard-dose steroids (TAC/MMF/STR, n=98). Mean change in height SDS was 0.16 +/- 0.32 with TAC/MMF/DAC and 0.03 +/- 0.32 with TAC/MMF/STR. The mean treatment group difference was 0.13 (p < 0.005 [95% CI 0.04-0.22]), 0.21 in prepubertal (p = 0.009 [95% CI 0.05-0.36]) and 0.05 in pubertal children (p = ns). Frequency of biopsy-proven acute rejection was 10.2%, TAC/MMF/DAC, and 7.1%, TAC/MMF/STR. Patient and graft survival and renal function were similar. Significantly greater reductions in total cholesterol and triglycerides but significantly higher incidences of infection and anemia were found with TAC/MMF/DAC (p < 0.05 all comparisons). Early steroid withdrawal significantly aided growth at 6 months more so in prepubertal than pubertal children. This was accompanied by significantly better lipid and glucose metabolism profiles without increases in graft rejection or loss.

PubMed Disclaimer

References

    1. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2006 Annual Report Available from http://spitfire.emmes.com/study/ped/resources/annlrept2006.pdf. Accessed July 2009.
    1. Fine RN, Ho M, Tejani A. The contribution of renal transplantation to final adult height: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 2001; 16: 951-956.
    1. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am 1996; 25: 699-717.
    1. Sarwal MM, Yorgin PD, Alexander S et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13-21.
    1. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M. Salvatierra. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003; 76: 1331-1339.

Publication types